Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea

C. Egea, J. Pinto, J. Ayuela, E. Ballester, C. Zamarron, A. Sojo, F. Barbe, HFCPAP Cooperative Group (Vitoria, Santander, Burgos, Barcelona, Compostela, Caceres, Mallorca, Spain)

Source: Annual Congress 2004 - Cardio-vascular function in OSA patients
Session: Cardio-vascular function in OSA patients
Session type: Thematic Poster Session
Number: 3478
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Egea, J. Pinto, J. Ayuela, E. Ballester, C. Zamarron, A. Sojo, F. Barbe, HFCPAP Cooperative Group (Vitoria, Santander, Burgos, Barcelona, Compostela, Caceres, Mallorca, Spain). Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea. Eur Respir J 2004; 24: Suppl. 48, 3478

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Time course of CPAP effects on central sleep apnoea in chronic heart failure
Source: Breathe 2009; 5: 355
Year: 2009

Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 103s
Year: 2002

Treatment of obstructive and central sleep apnoea in heart failure: practical options
Source: Eur Respir Rev 2007; 16: 183-188
Year: 2007



Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005


Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006


Respiratory failure in obstructive sleep apnea syndrome (OSAS)- is CPAP therapy alone adequate?
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005

Shift in sleep apnoea type in heart failure patients in the CANPAP trial
Source: Eur Respir J 2010; 35: 592-597
Year: 2010



The severity of central sleep apnoea syndrome in patients with chronic congestive heart failure is dependent on the quality of medical treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002

CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD
Source: Eur Respir J 2010; 35: 132-137
Year: 2010



Sleep apnoea in chronic heart failure
Source: Eur Respir Mon 2010; 50: 396-420
Year: 2010


CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002

CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

Chronic respiratory failure in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005

Coexistence of central sleep apnea or periodic breathing pattern in patients with congestive heart failure and obstructive sleep apnea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Efficacy of continuous positive airway pressure in treatment of patients with bradyarrhythmias associated with obstructive sleep apnoea syndrome
Source: Annual Congress 2006 - Cardiovascular consequences of obstructive sleep apnoea
Year: 2006

Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019